Lemzoparlimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lemzoparlimab, covering 2025-04-27 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS) [Phase 3]